STOCK TITAN

Corbus Pharmaceu (CRBP) Net Income by Year

CRBP

Corbus Pharmaceu reported a net loss of $78.5M in fiscal year 2025. This represents a decrease of 95.3% from the prior fiscal year. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters Corbus Pharmaceu has filed alongside them.

FY2025 annual
Net Income -$78.5M
YoY -95.3%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CRBP Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-K
Net Income-$78.5M-95.3%-$40.2M+9.9%-$44.6M-5.3%-$42.3M+7.2%-$45.6M+59.0%-$111.3M-55.7%-$71.5M-28.3%-$55.7M-71.7%-$32.4M-62.1%-$20.0M-126.0%-$8.9M-248.4%-$2.5M-321.8%-$602K

CRBP Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$35.0M-98.4%-$23.0M-35.3%N/A-$23.3M-69.4%-$17.7M-76.7%-$17.0M-146.1%N/A-$13.8M-37.1%-$10.0M-13.8%-$6.9M+61.1%N/A-$10.1M-14.5%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Corbus Pharmaceu financials

Frequently Asked Questions

What was Corbus Pharmaceu's net income in fiscal year 2025?

Corbus Pharmaceu reported a net loss of $78.5M in fiscal year 2025.

How fast is Corbus Pharmaceu's net income growing?

Corbus Pharmaceu (CRBP) net income fell by 95.3% year over year, from -$40.2M to -$78.5M in fiscal year 2025.

How has Corbus Pharmaceu's net income changed over the years?

Across the 13 fiscal years this page covers, Corbus Pharmaceu (CRBP) net income went from -$602K in fiscal year 2013 to -$78.5M in fiscal year 2025.

Corbus Pharmaceu (CRBP) reported -$35.0M in net income in Q2 2026. This represents a decrease of 98.4% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Corbus Pharmaceu (CRBP) reported on that line in every period on record.